MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1101/2025.09.16.25335186

Медицинская библиотека · medRxiv : the preprint server for health sciences · 2025

Germline Variants Influence Chronic Liver Disease Progression through Distinct Pathways.

Vujkovic Marijana, Kaplan David E, Ghouse Jonas, Loza Bao-Li, Brancale Joseph, Lewis Adam, Zhang David Y, Levin Michael G, Veatch Olivia J, Johnson Josephine P, Schneider Carolin V, Verma Anurag, Wangensteen Kirk J, Scorletti Eleonora, Gill Dipender, Konkwo Chigoziri, Garófalo Alexis M, Guare Lindsay A, Schwantes-An Tae-Wi, Abreu Marco V, Gellert-Kristensen Helene, Pedersen Ole B, Erikstrup Christian, Bundgaard Johan S, Sørensen Erik, Ostrowski Sisse R, Bundgaard Henning, Lee Kyung Min, Shaked Abraham, Olthoff Kim M, Hoteit Maarouf A, Speliotes Elizabeth K, Chen Yanhua, Oliveri Antonino, Yin Lishi, Valenti Luca Vc, Malvestiti Francesco, Marchelli Daniele, Miano Lorenzo, Anstee Quentin M, Daly Ann K, Cordell Heather J, Darlay Rebecca, Verweij Niek, Hindy George, Locke Adam, Matsuura Kentaro, Asrani Sumeet K, Testa Giuliano, Lotta Luca A, Jones Marcus B, Dochtermann Daniel R, Norden-Krichmar Trina M, Teerlink Craig C, Devineni Poornima, Pyarajan Saiju, Rader Daniel J, Tanaka Yasuhito, Voight Benjamin F, Vilarinho Silvia, Bastarache Lisa A, Stender Stefan, Tsao Philip S, Penn Medicine Biobank, DBDS Genomic Consortium, BioVU Biobank, Michigan Genomics Initiative, Regeneron Genetics Center, Indiana Biobank, All Of Us Research Program, Milano Biobank, LITMUS Consortium, VA Million Veteran Program, Morgan Timothy R, Lynch Julie A, Chang Kyong-Mi

СтатьяПрепринтПеревод в очереди

Аннотация

Cirrhosis and hepatocellular carcinoma (HCC) are long-term complications of chronic liver disease (CLD). In this large multi-ancestry genome-wide association study of all-cause cirrhosis (35,481 cases, 2.36M controls) and HCC (6,680 cases, 1.76M controls), we identified 27 loci associated with cirrhosis (10 novel) and 11 with HCC (three novel). Three novel cirrhosis loci were replicated in independent cohorts (e.g. FGF21, RPTOR, and IFNL3/4). Fifteen cirrhosis loci exhibited differential effects on cirrhosis risk via underlying etiologies, and six HCC loci influenced HCC risk indirectly via cirrhosis. In a gene-burden analysis of rare variants from whole-genome sequencing data in the VA Million Veteran Program (n=102,677), we identified GSTA5 as a novel cirrhosis-associated gene, while APOB and ATP9B were associated with and replicated for HCC. A high genetic risk score for cirrhosis was associated with a nearly doubled risk of CLD progressing to cirrhosis (HR=1.94, P=2×10-68) and of cirrhosis progressing to HCC (HR=1.65, P=7×10-08). Finally, among individuals with chronic hepatitis C who underwent antiviral therapy, cirrhosis risk was modified by variants in PNPLA3, IFNL3/4, and CD81 following pegylated interferon-α therapy, and by APOE lead variant following direct-acting antiviral therapy. These findings provide new insights into the complex genetic architecture of CLD progression with potential clinical and therapeutic implications.

Для цитирования: Vujkovic Marijana, Kaplan David E, Ghouse Jonas, Loza Bao-Li, Brancale Joseph, Lewis Adam, Zhang David Y, Levin Michael G, Veatch Olivia J, Johnson Josephine P, Schneider Carolin V, Verma Anurag, Wangensteen Kirk J, Scorletti Eleonora, Gill Dipender, Konkwo Chigoziri, Garófalo Alexis M, Guare Lindsay A, Schwantes-An Tae-Wi, Abreu Marco V, Gellert-Kristensen Helene, Pedersen Ole B, Erikstrup Christian, Bundgaard Johan S, Sørensen Erik, Ostrowski Sisse R, Bundgaard Henning, Lee Kyung Min, Shaked Abraham, Olthoff Kim M, Hoteit Maarouf A, Speliotes Elizabeth K, Chen Yanhua, Oliveri Antonino, Yin Lishi, Valenti Luca Vc, Malvestiti Francesco, Marchelli Daniele, Miano Lorenzo, Anstee Quentin M, Daly Ann K, Cordell Heather J, Darlay Rebecca, Verweij Niek, Hindy George, Locke Adam, Matsuura Kentaro, Asrani Sumeet K, Testa Giuliano, Lotta Luca A, Jones Marcus B, Dochtermann Daniel R, Norden-Krichmar Trina M, Teerlink Craig C, Devineni Poornima, Pyarajan Saiju, Rader Daniel J, Tanaka Yasuhito, Voight Benjamin F, Vilarinho Silvia, Bastarache Lisa A, Stender Stefan, Tsao Philip S, Penn Medicine Biobank, DBDS Genomic Consortium, BioVU Biobank, Michigan Genomics Initiative, Regeneron Genetics Center, Indiana Biobank, All Of Us Research Program, Milano Biobank, LITMUS Consortium, VA Million Veteran Program, Morgan Timothy R, Lynch Julie A, Chang Kyong-Mi. Germline Variants Influence Chronic Liver Disease Progression through Distinct Pathways.. medRxiv : the preprint server for health sciences. 2025. DOI: 10.1101/2025.09.16.25335186.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.